Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
The aim of the study was to verify the influence of Agaricus blazei (Murrill) ss. Heinemann (A. blazei) on the evolution of nutritional state and liver function in hepatitis C patients.
Condition | Intervention |
---|---|
Hepatitis C Nutritional Status Hepatitis, Viral, Human |
Dietary Supplement: Agaricus blazei (Murrill) ss. Heinemann (sun mushroom) |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
Official Title: | Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom) on the Nutritional State and Liver Biochemistry in Hepatitis C Patients. |
- Measure: influence of Agaricus blazei (Murrill) ss. Heinemann on the evolution of nutritional state and liver function in hepatitis C patients. Time Frame: six months [ Time Frame: Time Frame: six months ]
Enrollment: | 10 |
Study Start Date: | March 2003 |
Study Completion Date: | September 2004 |
Arms | Assigned Interventions |
---|---|
No Intervention: G1 |
Dietary Supplement: Agaricus blazei (Murrill) ss. Heinemann (sun mushroom)
Agaricus blazei powder, 10 grams/day, for 5 months
|
Experimental: G2 |
Dietary Supplement: Agaricus blazei (Murrill) ss. Heinemann (sun mushroom)
Agaricus blazei powder, 10 grams/day, for 5 months
|
Detailed Description:
Ten patients were studied (5 - GI - not taking A. blazei - and 5 - G2 - taking A. blazei), from both sexes, with positive Anti-VHC and a healthy nutritional state, admitted into in the viral hepatitis ward. Diagnosis and treatment for hepatitis C concurred with the regulations of the Ministry of Health and nutritional evaluation was performed in 3 moments according to anthropometrical, bioimpedance, biochemical and dietary standards, with duration of 6 months. The consumption of A. blazei (10g/day) in dehydrated powder was concomitant with antiviral therapy (conventional or pegylated interferon associated with ribavirin) with duration of 5 months.
Ages Eligible for Study: | 24 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- To have been informed and signed adequately the free and clarified assent
- Initiating the anti-viral treatment (interferon or pegylated interferon associate the ribavirin)
- Age: 24-70 years
- Gender :both the gender
- Race : all races
- To present serology positive to the anti-VHC ELISA
- To present genotype type 1,2,or 3
- Body mass index- >18,5 e < 35kg /m2
- Conditions full to the ORAL ingestion
Exclusion Criteria:
- Don't agree to the project or don't have signed the term of clarified free assent
- Restriction for oral ingestion
- The existence of surface of antigen of the hepatitis B virus(Ag HBs)
- The existence of antibody for the human immunodeficiency virus
- To be enclosed in another project of research or form of treatment
- Pregnant women
- Suckles
- Cirrhosis
- Patients with hepatitis auto-imune.
Brazil | |
Internal Medicine Department, Botucatu School of Medicine, São Paulo State University - UNESP | |
Botucatu, Sao Paulo, Brazil, 18618-000 |
Study Chair: | Caramori A Carlos, MD, PhD | Botucatu Medicine School - Sao Paulo State University |
No publications provided
ClinicalTrials.gov Identifier: | NCT00564811 History of Changes |
Other Study ID Numbers: | upeclin/HC/FMB-Unesp-03 |
Study First Received: | November 27, 2007 |
Last Updated: | November 27, 2007 |
Health Authority: | Brazil: National Committee of Ethics in Research |
Keywords provided by UPECLIN HC FM Botucatu Unesp:
Agaricus blazei (Murrill) ss. Heinemann, Hepatitis C Nutritional status Liver Function Tests Antiviral Agents |
Additional relevant MeSH terms:
Hepatitis Hepatitis A Hepatitis, Viral, Human Hepatitis C Liver Diseases Digestive System Diseases |
Virus Diseases Enterovirus Infections Picornaviridae Infections RNA Virus Infections Flaviviridae Infections |
ClinicalTrials.gov processed this record on October 17, 2012